ALC
$73.65-1.36 (-1.81%)
Alcon Inc.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), a...
Recent News
Transformational Opportunities: UBS Suggests 2 Longevity Stocks to Buy as the $8T Aging Boom Accelerates
For years, the conversation around getting older has focused on individuals – retirement, lifestyle, healthcare. But a bigger story has been quietly unfolding in the background. The U.S. population itself is aging, and that shift is starting to ripple far beyond personal milestones. The Chief Investment Office at UBS views this trend as a foundation for long-term portfolio positioning. It frames “longevity” as a structural theme – a growing, aging population with evolving needs, particularly in
Lifecore Biomedical CEO: Standalone CDMO Shift Complete, Utilization to Hit 60% by 2029
Lifecore Biomedical (NASDAQ:LFCR) CEO Paul Josephs told investors at a KeyBanc conference that the company has completed its transition into a “standalone CDMO” after divesting its former food businesses in 2022 and 2023. Josephs said Lifecore is now focused on two primary operations at its single s
BYND And LNSR Set The Tone Tuesday
Earnings concerns and deal collapse drive moves
Fed Kicks Off Policy Meeting as US Equity Futures Tread Water Pre-Bell
US equity futures were little changed ahead of Tuesday's opening bell as traders stayed on the sidel
Lensar to terminate Alcon merger agreement
Under the original agreement, Lensar will retain a $10m deposit.